How Akkure Genomics Solutions Can Help Improve Cancer Trial Recruitment
The era of precision medicine brings new opportunities to improve cancer trial recruitment. Akkure Genomics has developed an innovative solution, the Precision Cancer Trials Matcher. Our technology uses advanced algorithms to analyse a patient's genomic data, providing a precise match to relevant clinical trials.
Akkure Genomics' Cancer Trial Matcher is a model that matches patients and patient cohorts to potentially suitable cancer trials according to the trial’s eligibility criteria and patient data. By leveraging genomic variant types along with AI, Akkure brings a precision match for clinical trials. The system also features ongoing alerts to new trials matched to the patient, and our enterprise version features a smart contract system that captures informed consent digitally, ensuring organisations are compliant and auditable by leveraging blockchain technology.
By utilising our services, healthcare providers can streamline their recruitment process, reduce costs, and most importantly, ensure that patients are matched with trials that offer the best potential outcomes for their unique genetic profile.
You can explore our 3 distinct solutions below: